1350156--9/14/2010--PREAXIA_HEALTH_CARE_PAYMENT_SYSTEMS_INC.

related topics
{stock, price, share}
{acquisition, growth, future}
{product, market, service}
{stock, price, operating}
{customer, product, revenue}
{capital, credit, financial}
{cost, operation, labor}
{personnel, key, retain}
{property, intellectual, protect}
{competitive, industry, competition}
{control, financial, internal}
{financial, litigation, operation}
{interest, director, officer}
We have a limited operating history. We will need substantial additional financing in the future to continue operations. We will require key personnel. We have additional financing requirements. We may not be successful in the protection of intellectual property. We face competition and may not be able to compete successfully. We may face implementation delays. We may get limited customer feedback respecting products. We may face a slow down in developing markets. Our ability to keep current with technological changes impact on our ongoing business. We may have problems with our resolution of product deficiencies. We may not be able to effectively manage our growth. We have negative cash flow and absence of profits. Our directors and officers may face conflicts of interest. PreAxia does not have key man insurance. Acquisitions, investments and other strategic transactions could result in operating difficulties, dilution to our investors and other negative consequences. Fluctuations in quarterly operating results lead to unpredictability of revenue and earnings. Trading on the OTC Bulletin Board may be volatile and sporadic, which could depress the market price of our common stock and make it difficult for our shareholders to resell their shares. A decline in the price of our common stock could affect our ability to raise further working capital, it may adversely impact our ability to continue operations and we may go out of business. Because we do not intend to pay any cash dividends on our shares of common stock in the near future, our shareholders will not be able to receive a return on their shares unless they sell them. Our stock is a penny stock. Trading of our stock may be restricted by the SEC s penny stock regulations which may limit a shareholder s ability to buy and sell our stock. FINRA sales practice requirements may also limit a shareholder s ability to buy and sell our stock.

Full 10-K form ▸

related documents
1115975--4/15/2008--SILVERGRAPH_INTERNATIONAL_INC
1435936--8/30/2010--Real_Value_Estates_Inc
1073362--9/14/2009--Intelligent_Living_Corp
1073362--9/14/2010--Intelligent_Living_Corp
1172136--6/28/2007--US_GEOTHERMAL_INC
1011432--3/27/2009--AUXILIO_INC
1397645--1/29/2010--SOMBRIO_CAPITAL_CORP
1383097--10/29/2009--Search_By_Headlines.com_Inc.
1383097--10/28/2010--SEARCH_BY_HEADLINES.COM_CORP.
1332445--9/12/2008--Keewatin_Windpower_Corp.
1069489--4/15/2010--WESCORP_ENERGY_INC
852437--9/28/2006--AVATECH_SOLUTIONS_INC
928054--3/19/2008--FLOTEK_INDUSTRIES_INC/CN/
852437--9/28/2007--AVATECH_SOLUTIONS_INC
1332445--8/31/2009--Keewatin_Windpower_Corp.
740726--4/3/2007--BROADCAST_INTERNATIONAL_INC
1118037--3/31/2009--MATHSTAR_INC
1275548--3/27/2009--MIDWEST_URANIUM_CORP
1357594--9/30/2009--CLEAN_POWER_CONCEPTS_INC.
1103977--3/31/2008--RUBICON_FINANCIAL_INC
1013796--3/12/2007--TIB_FINANCIAL_CORP.
1121785--3/31/2006--SLS_INTERNATIONAL_INC
1393548--12/14/2010--Mine_Clearing_Corp.
1327238--5/18/2010--CYPLASIN_BIOMEDICAL_LTD.
1368195--5/4/2009--Aegean_Earth_&_Marine_CORP
826253--6/15/2009--AURA_SYSTEMS_INC
1082368--3/13/2006--BANCSHARES_OF_FLORIDA_INC
1445625--11/18/2009--NEXAIRA_WIRELESS_INC.
1445625--1/29/2010--NEXAIRA_WIRELESS_INC.
802257--9/28/2009--BRAIN_TREE_INTERNATIONAL_INC